The Leukemia & Lymphoma Society of Canada
Ryan O'Quinn is an experienced nonprofit professional currently serving as the National Business Development & Advancement Director at The Leukemia & Lymphoma Society of Canada since October 2018. In this role, Ryan co-develops national corporate strategies and establishes major gifts programming to enhance fundraising efforts for the blood cancer community. Previously, Ryan held various roles at The Leukemia & Lymphoma Society of Canada, including Regional Director for BC/Yukon, where responsibilities included recruiting volunteers, overseeing contributions, and communicating key messages about LLSC. Prior experience includes serving as Community Giving Manager and Membership and Development Coordinator at Ecology Action Centre, focusing on major gifts, membership growth, and strategic planning. Ryan began a career in fundraising as a Fundraising Manager at Public Outreach Fundraising, leading a team of canvassers for various organizations. Ryan holds a Bachelor's degree in Political Science with Honors in International Development Studies from Dalhousie University.
This person is not in any teams
The Leukemia & Lymphoma Society of Canada
The Leukemia & Lymphoma Society of Canada (LLSC) is a voluntary health agency dedicated to blood cancer. LLSC funds lifesaving blood cancer research across Canada and worldwide, and provides free information and support services. We won’t stop until there is a cure for leukemia, lymphoma, myeloma, myelodysplastic syndromes and myeloproliferative neoplasms and are able to improve the quality of life of people affected by blood cancers and their families by funding life-enhancing research and providing educational resources, services and support. Our strategy to achieve the mission is based on three areas of focus: research, patient support and advocacy. In 2017, we invested almost $7.4 million in the creation of programs and delivery of services to improve the lives of Canadians affected by blood cancers from coast to coast. This investment included a commitment of over $4.1 million in innovative, life-changing research to accelerate new cancer treatments, therapies, and cures; and $3.3 million towards funding patient services, programs and education across Canada. Everything we do is made possible through the generosity of individuals, corporate partners, and foundations. In the last two decades alone, the Leukemia & Lymphoma Society of Canada has raised $207 million for research and services. We receive no government support.